Desvenlafaxine Completed Phase 1 Trials for Vasomotor Symptoms Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00397176Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women